Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan

Elevated blood pressure (BP) is a major determinant of morbidity and mortality burden related to cardio‐metabolic risk. Current guidelines indicate that controlling and lowering BP promotes cardiovascular (CV) risk reduction. Among antihypertensive agents, angiotensin receptor blockers (ARBs) are ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Omboni, Stefano, Volpe, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Unsolicited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587798/
https://www.ncbi.nlm.nih.gov/pubmed/30358114
http://dx.doi.org/10.1111/1755-5922.12471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587798/
https://www.ncbi.nlm.nih.gov/pubmed/30358114
http://dx.doi.org/10.1111/1755-5922.12471

Ejemplares similares